About BioIntel.io

Purpose-built intelligence for the biotech regulatory landscape

BioIntel.io was created to solve a specific problem: the biotech and regenerative medicine industries generate an enormous volume of regulatory signals — FDA actions, clinical trials, enforcement patterns, research publications, funding rounds — and no existing tool synthesizes them into actionable intelligence. We built the platform we wished existed.

Our Mission

Democratize regulatory intelligence

Regulatory intelligence has historically been locked behind six-figure enterprise contracts, fragmented across dozens of government databases, and delivered in formats that require specialized training to interpret.

BioIntel.io makes institutional-grade signal detection, compliance analysis, and technology scouting accessible to every organization in the biologics and regenerative medicine ecosystem — from two-person startups to enterprise compliance teams.

Signals Monitored Monthly10,000+
Regulatory Frameworks50+
Data Sources25+
Avg. Signal Latency<30 min

Platform Pillars

Four layers of intelligence

Signal Detection

Continuous monitoring of FDA actions, FTC enforcement, clinical trial registrations, patent filings, funding rounds, and peer-reviewed research across the entire biologics and regenerative medicine landscape.

Compliance Analysis

AI-powered claim screening against 21 CFR 1271, FDA 351(a)/351(k) pathways, FTC Act Section 5, DSHEA, and state-level regulations — with specific citations and compliant alternative language.

Technology Momentum

Proprietary composite scoring that ranks emerging technologies by research velocity, trial activity, venture funding, regulatory signals, and commercial traction — updated continuously.

Predictive Intelligence

Pattern recognition across regulatory timelines, enforcement trends, and funding cycles to surface actionable insights before they become consensus.

Built For

Who uses BioIntel.io

Compliance Officers

Screen marketing claims against FDA/FTC frameworks before they become enforcement targets.

Regulatory Affairs

Track FDA guidance, pathway changes, and enforcement actions in real time.

Biotech Investors

Identify technology momentum shifts and regulatory risks before they move markets.

Clinical Operations

Monitor trial landscape changes, competitor filings, and regulatory pathway updates.

Executive Leadership

Strategic intelligence briefs that synthesize signals into actionable board-level insights.

Legal Counsel

Evidence-backed regulatory risk assessments with specific citation chains.

Ready to see what you're missing?

Start with a free claim analysis or explore the live intelligence feed.